Omada Health (NASDAQ:OMDA) CEO Sells $509,530.64 in Stock

Key Points

• CEO Sean Duffy sold 21,572 Omada Health shares for approximately $509,531 at an average price of $23.62, reducing his direct stake by 4.98% to 411,861 shares.
• Omada Health shares fell 4.4% to $22.29, while the company reported quarterly revenue of $87.83 million and EPS of $0.08, exceeding analyst expectations.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $26.50; several firms recently raised their targets.

Omada Health, Inc. (NASDAQ:OMDA - Get Free Report) CEO Sean Duffy sold 21,572 shares of the company's stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $23.62, for a total value of $509,530.64. Following the completion of the transaction, the chief executive officer directly owned 411,861 shares of the company's stock, valued at approximately $9,728,156.82. This trade represents a 4.98% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Omada Health Trading Down 4.4%

OMDA traded down $1.02 on Thursday, hitting $22.29. 1,369,688 shares of the company's stock traded hands, compared to its average volume of 1,251,782. The company's 50 day simple moving average is $22.59 and its 200-day simple moving average is $17.46. Omada Health, Inc. has a one year low of $10.28 and a one year high of $26.92. The firm has a market cap of $1.36 billion, a price-to-earnings ratio of 445.80 and a beta of 1.86.

Omada Health (NASDAQ:OMDA - Get Free Report) last announced its quarterly earnings data on Thursday, August 6th. The company reported $0.08 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.02) by $0.10. Omada Health had a net margin of 1.39% and a return on equity of 2.60%. The business had revenue of $87.83 million during the quarter, compared to analyst estimates of $80.93 million. As a group, equities analysts anticipate that Omada Health, Inc. will post 0.09 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several brokerages have recently issued reports on OMDA. Wall Street Zen raised Omada Health from a "hold" rating to a "buy" rating in a report on Saturday, August 8th. Citigroup reaffirmed an "outperform" rating on shares of Omada Health in a research note on Friday, August 14th. JPMorgan Chase & Co. upped their price objective on Omada Health from $26.00 to $30.00 and gave the stock an "overweight" rating in a report on Friday, August 14th. BTIG Research raised their target price on shares of Omada Health from $30.00 to $35.00 and gave the company a "buy" rating in a report on Monday, August 10th. Finally, Morgan Stanley restated an "overweight" rating and issued a $30.00 target price on shares of Omada Health in a report on Monday, June 22nd. Eleven equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, Omada Health presently has a consensus rating of "Moderate Buy" and an average target price of $26.50.

Institutional Investors Weigh In On Omada Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Raymond James Financial Inc. purchased a new position in shares of Omada Health during the second quarter worth approximately $32,000. Quarry LP bought a new stake in shares of Omada Health in the fourth quarter valued at about $29,000. Versant Capital Management Inc grew its holdings in Omada Health by 319.3% during the 2nd quarter. Versant Capital Management Inc now owns 2,998 shares of the company's stock worth $66,000 after acquiring an additional 2,283 shares in the last quarter. Legal & General Group Plc bought a new stake in shares of Omada Health in the 2nd quarter valued at about $76,000. Finally, JPMorgan Chase & Co. purchased a new stake in shares of Omada Health in the 3rd quarter worth approximately $82,000.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company's platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source